Literature DB >> 2328395

Locomotor activity in rats after administration of nicotinic agonists intracerebrally.

C Reavill1, I P Stolerman.   

Abstract

1. Nicotine (0.13 and 0.4 mg kg-1, s.c.) increased the ambulatory component of locomotor activity in rats previously exposed to the drug. Nicotine did not increase repeated movements reliably. 2. An infusion of either nicotine (8 micrograms) or the potent nicotinic agonist cytisine (4 micrograms) into the ventral tegmental area of the forebrain increased ambulation but not repeated movements. 3. An infusion of nicotine or cytisine into the nucleus accumbens, striatum, dorsal hippocampal formation or motor thalamus did not increase ambulatory or repeated movements. 4. Mecamylamine (0.1-1.0 mg kg-1, s.c.) blocked increases in locomotor activity produced by an infusion of nicotine or cytisine into the ventral tegmental area. 5. The locomotor activity produced by systemically administered nicotine may be mediated, in part, through nicotinic receptors located in the ventral tegmental area of the mesolimbic dopamine system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328395      PMCID: PMC1917396          DOI: 10.1111/j.1476-5381.1990.tb14693.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour.

Authors:  R L Fog; A Randrup; H Pakkenberg
Journal:  Psychopharmacologia       Date:  1967

2.  The occurrence of tolerance to a central depressant effect of nicotine.

Authors:  C F Morrison; J A Stephenson
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

3.  Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens.

Authors:  A J Pijnenburg; J M van Rossum
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

4.  Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine.

Authors:  L T Meltzer; J A Rosecrans
Journal:  Pharmacol Biochem Behav       Date:  1981-07       Impact factor: 3.533

5.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

6.  Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain.

Authors:  R D Schwartz; J Lehmann; K J Kellar
Journal:  J Neurochem       Date:  1984-05       Impact factor: 5.372

7.  [D-TRP11]-neurotensin, unlike alpha-flupenthixol, may not block amphetamine-induced hyperactivity in rats.

Authors:  A Sahgal; A B Keith; S Lloyd; J A Edwardson
Journal:  Neuropharmacology       Date:  1989-03       Impact factor: 5.250

8.  Characterization of the locomotor stimulant action of nicotine in tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

9.  The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

View more
  32 in total

1.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Selective dopamine antagonists reduce nicotine self-administration.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.

Authors:  Vincenzo Di Matteo; Massimo Pierucci; Arcangelo Benigno; Ennio Esposito; Giuseppe Crescimanno; Giuseppe Di Giovanni
Journal:  CNS Neurosci Ther       Date:  2010-03-25       Impact factor: 5.243

4.  Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells.

Authors:  J S Yeomans; J Takeuchi; M Baptista; D D Flynn; K Lepik; J Nobrega; J Fulton; M R Ralph
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Discriminative stimulus effects of mecamylamine and nicotine in rhesus monkeys: Central and peripheral mechanisms.

Authors:  Colin S Cunningham; Megan J Moerke; Lance R McMahon
Journal:  Pharmacol Biochem Behav       Date:  2019-02-06       Impact factor: 3.533

6.  The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.

Authors:  Paul J Fletcher; Judy Sinyard; Guy A Higgins
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

7.  Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.

Authors:  M E Benwell; D J Balfour; H M Lucchi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.

Authors:  M Shoaib; M E Benwell; M T Akbar; I P Stolerman; D J Balfour
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.

Authors:  M E Benwell; P E Holtom; R J Moran; D J Balfour
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.

Authors:  P Whiteaker; H S Garcha; S Wonnacott; I P Stolerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.